Skip to main content

Table 3 Adverse Events of Chemotherapy in the Two Groups

From: Oxaliplatin-dacarbazine combination chemotherapy for the treatment of advanced soft tissue sarcoma of the limbs

AE

Grade (CTCAEv3.0)

Experimental group (cases)

Control group (cases)

p value

Nausea

1 (mild)

9

10

>0.05

 

2 (moderate)

4

5

 

Vomiting

1 (mild)

5

7

>0.05

 

2 (moderate)

1

1

 

Asthenia

1 (mild)

6

4

>0.05

 

2 (moderate)

0

0

 

Granulocytopenia

1 (mild)

7

8

>0.05

 

2 (moderate)

2

0

 

Anaemia

1 (mild)

2

1

>0.05

 

2 (moderate)

0

0

 

Peripheral Neuropathy

1 (mild)

12

0

Not Comparable

 

2 (moderate)

3

0

Â